An integrated analysis of human carotid plaque transcriptomes and macrophage experiments suggests that elevated BCAP31 in ...

At least a quarter of Americans suffer from high levels of cholesterol or fatty acids in their bloodstream, a condition ...

A targeted epigenomic study of advanced carotid plaques reveals coordinated DNA hypomethylation of microRNA regulatory regions linked to plaque instability, metabolic syndrome, and stroke history.

Lipoprotein(a), or Lp(a), is a genetically determined blood lipid and an important risk factor for cardiovascular disease.

Elucid Bioimaging Inc. (“Elucid”) today reaffirmed its commitment to advancing its mission – the prediction and personalization of the prevention of heart attack and stroke – and its confidence in the ...

What if a saturated fat could reverse heart disease? New research reveals how gut bacteria produce a surprising molecule that ...

As Davina McCall reveals she has cardiovascular disease, doctors explain the nine things every woman should know about her ...

Researchers at the UC Davis National Center for Interventional Biophotonic Technologies (NCIBT) have concluded the first-in-human test of a new device that could help doctors better detect and treat ...

The ELUCIDATE FFR-CT study, which supported Elucid's recent US FDA 510 (k) clearance of FFR-IQ, demonstrated an overall sensitivity of 92.2% and specificity of 93.1%, the highest of any FFR-CT ...

IQ, introducing BioIntegrated FFR-CT with 92.2% sensitivity and 93.1% specificity to evaluate coronary ischemia.

Polluted air can do more than damage the lungs. Cardiologists explain how PM2.5 particles trigger inflammation, affect blood ...

AI has made a significant impact on the way clinicians use CCTA. For example, what were once time-consuming manual ...